Eli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s ...

The United Kingdom's healthcare regulator on Friday said it had made the world's largest seizure of illegal weight loss ...

Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...

Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...

Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) seized the world's largest cache of unlicensed ...

The EMA is working with social media content creators to try to encourage "safe and responsible" use of weight-loss drugs.

Eli Lilly jumps to top 10% in quality rankings, showing strong fundamentals even as Trump pushes for weight loss drug price ...

Eli Lilly's rival Novo Nordisk plans to retail both Ozempic and Wegovy in India as diabetes and weight-loss drugs, ...

Shares of Eli Lilly and Novo Nordisk fell Friday, Oct. 17 after Pres. Donald Trump said the price of the weight-loss drug Ozempic could soon drop to $150 a month.

Prescribing rates remained stable from June to September, according to an analysis of EHR data from researchers at Truveta — a platform that includes ...

Prescription-drug costs were the top-cited factor for rising premiums, according to large businesses surveyed by the think tank. Two-thirds of large businesses said GLP-1s for weight loss had a ...